Shenzhen Glory Medical Co.,Ltd.
Symbool: 002551.SZ
SHZ
3.25
CNYMarktprijs vandaag
-16.6251
Koers/Winst Verhouding
0.6657
Koers/Winst Groei Verhouding
2.75B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Shenzhen Glory Medical Co.,Ltd. (002551-SZ) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 3585.05 | 818.2 | 920.1 | 1088.9 | |||||||||||||||||
balance-sheet.row.short-term-investments | 1239.9 | 327.9 | 434.9 | 292.5 | |||||||||||||||||
balance-sheet.row.net-receivables | 2831.97 | 611 | 653.9 | 871.2 | |||||||||||||||||
balance-sheet.row.inventory | 1558.23 | 371.5 | 416.8 | 375.9 | |||||||||||||||||
balance-sheet.row.other-current-assets | 409.81 | 21.9 | 37.4 | 57.4 | |||||||||||||||||
balance-sheet.row.total-current-assets | 8137.23 | 1822.7 | 2028.2 | 2393.4 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2001.82 | 488.8 | 556 | 637.6 | |||||||||||||||||
balance-sheet.row.goodwill | 27.57 | 1.4 | 12.4 | 68.6 | |||||||||||||||||
balance-sheet.row.intangible-assets | 1099.93 | 280.4 | 510 | 275.6 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1127.5 | 281.8 | 522.4 | 344.2 | |||||||||||||||||
balance-sheet.row.long-term-investments | -434.24 | -194.7 | -288.1 | 90.1 | |||||||||||||||||
balance-sheet.row.tax-assets | 356.29 | 103.9 | 137.4 | 93.1 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 5026.85 | 1429.3 | 1304.6 | 1414.8 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 8078.22 | 2109.1 | 2232.3 | 2579.8 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 16215.46 | 3931.7 | 4260.5 | 4973.2 | |||||||||||||||||
balance-sheet.row.account-payables | 1419.65 | 381.9 | 380 | 447.1 | |||||||||||||||||
balance-sheet.row.short-term-debt | 71.74 | 21.1 | 41.5 | 61.1 | |||||||||||||||||
balance-sheet.row.tax-payables | 235.77 | 73.8 | 81.2 | 97.8 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 1106.62 | 269.5 | 290.6 | 331.1 | |||||||||||||||||
Deferred Revenue Non Current | 244.94 | 80.4 | 84.3 | 75 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.67 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 515.54 | 24.2 | 237.1 | 7.5 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1443.15 | 354.2 | 379 | 417.4 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-liab | 4829.33 | 1184 | 1261.2 | 1526.8 | |||||||||||||||||
balance-sheet.row.preferred-stock | 126.64 | 59.5 | 65.2 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 3379.16 | 844.8 | 844.8 | 844.7 | |||||||||||||||||
balance-sheet.row.retained-earnings | 2105.02 | 429.8 | 578.7 | 829.7 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1074.15 | -59.5 | -65.2 | 42.5 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 4092.28 | 1339.6 | 1333.6 | 1403.8 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 10777.25 | 2614.2 | 2757.1 | 3120.7 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 16215.46 | 3931.7 | 4260.5 | 4973.2 | |||||||||||||||||
balance-sheet.row.minority-interest | 608.88 | 133.6 | 242.2 | 325.7 | |||||||||||||||||
balance-sheet.row.total-equity | 11386.13 | 2747.8 | 2999.3 | 3446.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 16215.46 | - | - | - | |||||||||||||||||
Total Investments | 805.66 | 133.1 | 146.8 | 382.6 | |||||||||||||||||
balance-sheet.row.total-debt | 1178.36 | 290.6 | 332.1 | 392.2 | |||||||||||||||||
balance-sheet.row.net-debt | -1166.79 | -199.7 | -153.2 | -404.2 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -142.04 | -327.9 | 88 | 369.9 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 37.4 | 125 | 76.7 | 55.1 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -44.4 | -1.2 | -1.1 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 44.4 | 1.2 | 1.1 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 37.9 | -90.4 | 57.9 | 30.6 | ||||||||||||||||
cash-flows.row.account-receivables | 29.17 | 156.3 | 49.6 | 116.2 | ||||||||||||||||
cash-flows.row.inventory | 8.73 | -55.9 | -38.6 | -41 | ||||||||||||||||
cash-flows.row.account-payables | 0 | -146.4 | 48.1 | -43.5 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | -44.4 | -1.2 | -1.1 | ||||||||||||||||
cash-flows.row.other-non-cash-items | -8.88 | 389.7 | 20 | 41.9 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -162.73 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -48.06 | -57.3 | -430 | -254.2 | ||||||||||||||||
cash-flows.row.acquisitions-net | 1.23 | 1.5 | 0.5 | -67.1 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -814.88 | -865.4 | -1221 | -295.2 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 863.05 | 732.6 | 1087.2 | 473.3 | ||||||||||||||||
cash-flows.row.other-investing-activites | 84.27 | 11.7 | -0.1 | -5.4 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 85.43 | -176.8 | -563.4 | -148.6 | ||||||||||||||||
cash-flows.row.debt-repayment | -103.35 | -88.8 | -248.4 | -204.2 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0.19 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.19 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | -57.3 | -164 | -30.3 | -49.8 | ||||||||||||||||
cash-flows.row.other-financing-activites | 52.56 | 61.7 | 287 | 338.9 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -45.97 | -191.1 | 8.3 | 84.9 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -8.8 | 6.1 | 4.7 | -20.3 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -132.06 | -265.4 | -307.7 | 413.6 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1983.54 | 387.2 | 652.6 | 960.4 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 2115.6 | 652.6 | 960.4 | 546.8 | ||||||||||||||||
cash-flows.row.operating-cash-flow | -162.73 | 96.5 | 242.6 | 497.5 | ||||||||||||||||
cash-flows.row.capital-expenditure | -48.06 | -57.3 | -430 | -254.2 | ||||||||||||||||
cash-flows.row.free-cash-flow | -210.79 | 39.2 | -187.4 | 243.3 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1159.63 | 1192.9 | 1275.7 | 1790.3 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 972.72 | 995.3 | 1053.8 | 1427.4 | |||||||||||||||||
income-statement-row.row.gross-profit | 186.91 | 197.6 | 221.9 | 362.9 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 40.19 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 35.16 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 18.79 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -6.91 | -6.4 | 115.4 | 100.6 | |||||||||||||||||
income-statement-row.row.operating-expenses | 187.94 | 217.5 | 228.4 | 267.9 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 1160.66 | 1212.8 | 1282.3 | 1695.3 | |||||||||||||||||
income-statement-row.row.interest-income | 11.44 | 8.7 | 6.9 | 5.2 | |||||||||||||||||
income-statement-row.row.interest-expense | 1.74 | 2 | 4.4 | 7.2 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 18.79 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 13.28 | -6.4 | -385.2 | -37.7 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -6.91 | -6.4 | 115.4 | 100.6 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 13.28 | -6.4 | -385.2 | -37.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 1.74 | 2 | 4.4 | 7.2 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 141.73 | 95.9 | 125 | 76.7 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 14.82 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -126.91 | -121.2 | 0.8 | 126.7 | |||||||||||||||||
income-statement-row.row.income-before-tax | -113.63 | -127.6 | -384.4 | 89.1 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 36.6 | 33.2 | -56.5 | 1 | |||||||||||||||||
income-statement-row.row.net-income | -142.04 | -148.9 | -327.9 | 88 |
Vaak gestelde vragen
Wat is Shenzhen Glory Medical Co.,Ltd. (002551.SZ) totale activa?
Shenzhen Glory Medical Co.,Ltd. (002551.SZ) totale activa is 3931719261.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is 550234370.000.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.166.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -0.125.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -0.102.
Wat is Shenzhen Glory Medical Co.,Ltd. (002551.SZ) nettowinst (netto-inkomen)?
De nettowinst is -148889156.240.
Wat is de totale schuld van het bedrijf?
De totale schuld is 290603679.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 217491767.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 616750849.000.